carbamates and olaparib

carbamates has been researched along with olaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chu, W; Chu, Y; Mach, RH; Makvandi, M; Mankoff, J; McDonald, ES; Zeng, C	1

Other Studies

1 other study(ies) available for carbamates and olaparib

Article	Year
Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells. Biochemical and biophysical research communications, 2017, 05-06, Volume: 486, Issue:3 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azabicyclo Compounds; Carbamates; Cell Death; Cell Line, Tumor; Drug Synergism; Epithelial Cells; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Inhibitory Concentration 50; Mice; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Receptors, sigma	2017

Article

Year

Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells.

Biochemical and biophysical research communications, 2017, 05-06, Volume: 486, Issue:3

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azabicyclo Compounds; Carbamates; Cell Death; Cell Line, Tumor; Drug Synergism; Epithelial Cells; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Inhibitory Concentration 50; Mice; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Receptors, sigma

2017